Lisa A. Conte
Net Worth

Last updated:

What is Lisa A. Conte net worth?

The estimated net worth of Ms. Lisa A. Conte is at least $3,692,716 as of 17 May 2024. She owns shares worth $16,246 as insider and has received compensation worth at least $3,676,470 in Jaguar Health, Inc..

What is the salary of Lisa A. Conte?

Ms. Lisa A. Conte salary is $525,210 per year as Founder, Chief Executive Officer, Pres & Director in Jaguar Health, Inc..

How old is Lisa A. Conte?

Ms. Lisa A. Conte is 66 years old, born in 1959.

What stocks does Lisa A. Conte currently own?

As insider, Ms. Lisa A. Conte owns shares in one company:

Company Title Shares Price per share Total value
Jaguar Health, Inc. (JAGX) Founder, Chief Executive Officer, Pres & Director 8,003 $2.03 $16,246

What does Jaguar Health, Inc. do?

Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.

JAGX logo
JAGX
Jaguar Health, Inc.
$2.03

Lisa A. Conte insider trading

Jaguar Health, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted stock units 2,695 N/A N/A
Option
Common Stock 2,695 N/A N/A
Option
Common Stock 600 N/A N/A
Option
Restricted stock units 2,694 N/A N/A
Option
Common Stock 2,694 N/A N/A
Option
Common Stock 45,000 N/A N/A
Purchase
Common Stock 7,968 $2.51 $20,000
Purchase
Bridge Warrant to Purchase Common Stock 37,500 $2 $75,000
Purchase
Common Stock 1,500 $1.11 $1,668

Jaguar Health key executives

Jaguar Health, Inc. executives and other stock owners filed with the SEC:

  • Dr. Steven R. King (67) Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
  • Mr. Jonathan S. Wolin CPA, J.D., M.B.A. (63) Chief of Staff, Chief Compliance Officer & Gen. Counsel
  • Ms. Lisa A. Conte (66) Founder, Chief Executive Officer, Pres & Director